CAS 1421936-85-7
:Iclepertin
Formule :C20H18F6N2O5S
InChI :InChI=1S/C20H18F6N2O5S/c1-10(19(21,22)23)32-14-4-3-12(34(2,30)31)5-13(14)17(29)28-8-11-7-18(11,9-28)15-6-16(33-27-15)20(24,25)26/h3-6,10-11H,7-9H2,1-2H3/t10-,11+,18+/m1/s1
Code InChI :MYHDQTVHHMSLEF-DDBGAENHSA-N
SMILES :C[C@H](C(F)(F)F)OC1=C(C=C(C=C1)S(=O)(=O)C)C(=O)N2C[C@@H]3C[C@@]3(C2)C4=NOC(=C4)C(F)(F)F
Synonymes :- [5-Methanesulfonyl-2-((R)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-[(1R,5R)-1-(5-trifluoromethyl-isoxazol-3-yl)-3-aza-bicyclo[3.1.0]
- Methanone, [5-(methylsulfonyl)-2-[(1R)-2,2,2-trifluoro-1-methylethoxy]phenyl][(1R,5R)-1-[5-(trifluoromethyl)-3-isoxazolyl]-3-azabicyclo[3.1.0]hex-3-yl]-
- [5-Methanesulfonyl-2-((R)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-[(1R,5R)-1-(5-trifluoromethyl-isoxazol-3-yl)-3-aza-bicyclo
- Iclepertin
- Iclepertin (BI-425809)
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
6 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
Iclepertin
CAS :Iclepertin (BI-425809) is a GlyT1 inhibitor.Iclepertin is used for the treatment of Alzheimer;s disease and other CNS disorders.Formule :C20H18F6N2O5SDegré de pureté :99.21% - 99.66%Couleur et forme :SolidMasse moléculaire :512.423(5-(Methylsulfonyl)-2-(((R)-1,1,1-trifluoropropan-2-yl)oxy)phenyl)((1R,5R)-1-(5-(trifluoromethyl)isoxazol-3-yl)-3-azabicyclo[3.1.0]hexan-3-yl)methanone
CAS :Formule :C20H18F6N2O5SDegré de pureté :99%Masse moléculaire :512.4227Iclepertin
CAS :(5-(Methylsulfonyl)-2-(((R)-1,1,1-trifluoropropan-2-yl)oxy)phenyl)((1R,5R)-1-(5-(trifluoromethyl)isoxazol-3-yl)-3-azabicyclo[3.1.0]hexan-3-yl)methanoneFormule :C20H18F6N2O5SDegré de pureté :99%Masse moléculaire :512.42[5-(Methylsulfonyl)-2-[(1R)-2,2,2-trifluoro-1-methylethoxy]phenyl][(1R,5R)-1-[5-(trifluoromethyl)-3-isoxazolyl]-3-azabicyclo[3.1.0]hex-3-yl]-methanone
CAS :Produit contrôléFormule :C20H18F6N2O5SCouleur et forme :NeatMasse moléculaire :512.423BI 425809
CAS :BI 425809 is a drug that belongs to the class of selective serotonin reuptake inhibitors (SSRIs) and has been shown in clinical studies to be effective in the treatment of depression. The safety profile of BI 425809 has been established in clinical trials with healthy Chinese subjects, where it was found that the drug had no harmful effects at doses up to 400 mg/day. The concentration-time curve for BI 425809 showed an interactive response with food intake, which may indicate a need for dosage adjustment when taken with food. Pharmacokinetic properties have been evaluated in healthy Chinese subjects, showing that oral absorption is rapid and complete; elimination is mainly by hepatic metabolism; and elimination half-life is approximately 12 hours. BI 425809 has a low potential for abuse as it does not bind to dopamine receptors or produce any rewarding effects.Degré de pureté :Min. 95%





